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1In 1993, the California Supreme Court handed down a decision in the case
Ramirez v. Plough. Inc.1 holding that manufacturers of nonprescription drugs
in that state have no duty under the tort law to print mandatory warnings in
any language other than English. It was a question of rst impression not only
for California, but for the nation, and the public policy issues it raised were
among the most dicult in food and drug law: whom should our food and drug
laws protect, and is a gain in eciency worth even a small cost in human life?
Further, this case raised a broader, equally dicult question about the very
identity of our immigrant nation:
when an immigrant chooses not to learn English, how willing are we to
change our institutions to accommodate that decision?
Hesistant to engage in such weighty public policy-making, the California
court expressly deferred to the legislature, and in so doing issued an invita-
tion which advocates on both sides hope Congress{or the Food and Drug Ad-
ministration (FDA) through rulemaking|-will seize upon to resolve the issue
of foreign-language labelling of food and drugs. Possible solutions include a
European|style decree of English as the ocial language of the United States,
case-by-case adjudication based on a reasonable man standard, or federal and
state mandates of labelling in several languages, among other possible solutions.
While each has its clear advantages, when each solution is considered in turn
relative to its suitability to the specic needs of the United States, a picture
emerges of the U.S. as a country in which a
2European-style English only policy would best give way to a more exible
solution.
Manufacturers of food and drugs in the U.S. are currently under no explicit
duty to label in any language other than English. The regulations implementing
the Food, Drug and Cosmetic Act provide that (a] 11 words, statements, and
other information required by or under authority of the act to appear on the label
or labeling shall appear thereon in the English language: Provided, however,
That in the case of articles distributed solely in the Commonwealth of Puerto
Rico or in a Territory where the predominant language is one other than English,
the predominant language may be substituted for English.2 While the FDA
regulations expressly encourage the preparation of labeling to meet the needs
of non-English speaking or special user populations,3 this is permissible only as
long as other requirements are met. One such requirement is that if the label or
packaging of the food or drug distributed in the U.S. contains any representation
in a foreign language then all required words, statements and other information
must appear in the foreign language as well as in English.4 Signicantly, though,
use of label space for any representation in a foreign language is not a basis
to exempt a manufacturer from the general obligation to make the required
language conspicuous and prominent.5
Such was the statutory backdrop to the Ramirez case.6 In that case, mother
Rosa Rivera fed her four|month|old baby St. Joseph's Aspirin for Children,
unaware of the warnings printed only in English that aspirin should not be
administered to children under
3certain conditions. Her son Jorge was rendered blind, quadriplegic and men-
tally impaired, a victim of a rare but devastating disease called Reye's syndrome.
When she sued Plough, Inc., the manufacturer of the aspirin, for negligent failure
to warn and strict liability, she was aided by the ACLU and other activist groups
who hailed the case as a potential landmark in terms of language discrimination7
and the rights of consumers who do not speak English. The case was further
complicated by the fact that Plough carried on aggressive Spanish-language
marketing of its aspirin, although Ms. Rivera herself had not been exposed to
any of the advertisements.
The California Court of Appeals reversed the district court's grant of sum-
mary judgment in favor of Plough, Inc., who had pled statutory compliance as
well as public policy reecting the status of English as the ocial language. Tak-
ing note of the FDA's regulations which encourage foreign-language labelling,
the Court of Appeals wrote that these regulations demonstrate that public pol-
icy does not forbid requiring warnings in languages other than English where
appropriate.' Cases from other jurisdictions had included users' diculties with
English as part of a negligence analysis,9 at least one treatise had recognized
that manufacturers may be required to warn in a language other than English
if some users are not likely to understand English,'0 and the Court of Appeals
sent the case to the jury on the question of the adequacy of the English-only
warning.
The California Supreme Court, however, reversed the appeals court. While
recognizing that the courts were the proper body to
4determine the standard of care once a duty was established, the Supreme
Court found that the reasonable man standard chosen by the appeals court
was inappropriate in the case of foreign|language labelling. A great deal of
information-gathering on costs, eciency, feasibility and the ultimate benet
to be derived from labelling must be rst undertaken, the court explained, and
therefore the prudent course is to adopt for tort purposes the existing legislative
and administrative standard of care on this issue. gill
Thus, the public policy question of how much special consideration should
be given to those who have diculty with the English language in the context of
food and drug law was handed to the legislatures and the FDA.'2 As the Ramirez
case well illustrates, this is not merely an issue of immigrants achieving a level
of comfort in their new society, it can be a question of life or death. This is true
particularly as relates to drug labeling, but the consumer who cannot recognize
the name of a dangerous allergen in English on a food label is no less in danger.
Moreover, foreign language accommodation would aect a much larger sector
of our society than most people are aware: the 1990 Census revealed that 32
million people in the U.S., or 13% of the population, speak some language other
than English at home.13
The rst option for the legislature is take an ocial English stance. Assum-
ing more activist courts in other states do not view the statutory background
in a way very dierent from California's highest court, this could mean no par-
ticular legislative action is necessary. Alternatively, Congress might
5approach the politically sensitive issue of English as the ocial language of
the United States. Surveys show that there would be an tremendous amount of
support for ocial English legislation, seventy-eight percent of registered voters
indicating that they would favor such a measure.'4 Further more, of respondents
with a native language other than English, eighty-eight percent said they did
not believe the measure would discriminate against them.15
Other diverse communities have also had to grapple with the question of
foreign-language labeling. The solution adopted by the European Community
is best characterized as an ocial language policy, and perhaps U.S. legislators
or FDA decision-makers would benet from an examination of their system
of labeling. At least when compared to other areas of the world, Europe is
after all very similar to the U.S. as concerns their ethos of consumer protection,
technological advancement, and even some cultural perspectives.
European Community (EC) law mandates that the required information
on pharmaceutical labels shall appear in the ocial language or languages of
the Member State where the product is placed on the market.16 Further, this
provision shall not prevent those particulars from being indicated in several
languages, provided that they appear in all the languages used.'7 Ingredient
and nutrition labeling on food is treated dierently, however:
Member States shall ensure that the information covered by [relevant law]
appears in a language easily understood by purchasers, unless other measures
have been taken to ensure that the purchaser is informed. This provision shall
not prevent such information from being indicated in more than one language.
~
Although the latter provision appears to be more exible and
6potentially more consumer|protective than the provision for ocial|language
labeling on drugs, it is not understood as such in the EC. In fact, as a member
of the European Parliament explained, the meaning of the phrase easily un-
derstood by purchasers is in practice English, French, German or Spanish [is)
sucient.19 Consumers in minor language areas, he noted, are evidently of very
little importance to (the lawmaking body20).2' Consumer advocates in the EC
evidently have a much more dicult task before them than their U.S. counter-
parts; with the advent of the Single Market, Greek consumers in Greece could
conceivably be confronted with food labelled only in English or another one of
the four dominant European languages.
Apparently the plight of the newly-arrived immigrant, speaking only Arabic
or Turkish, is of even less concern to European lawmakers. This is notable
because the numbers of such foreigners living in Europe is not insignicant;
excluding Americans and EC nationals living in each others' countries, 2.3%
of the EC's inhabitants are foreign citizens (as compared to a not-much-higher
3.7% in the U.S.).~ Yet research revealed no visible movement on the part of
consumer advocates to protect these residents. In fact, debate in the European
Parliament{the body understood to be most responsive to popular sentiment
and consumer groups|-showed that such groups are currently most concerned
about changing the food labeling law to the more protective ocial language of
the Member State requirement found in the drug laws.
That a system based on a declaration of an ocial language which all resi-
dents must learn is found perfectly acceptable to
7Europeans might bode well for its proponents here in the United States.
Its administrative simplicity in diversely populated areas is admirable, and al-
though some consumers are not specically accommodated, it would be dicult
to characterize the European law as inhumane. Further, it promotes business
in that a more complex standard might inhibit some manufacturers from enter-
ing the market for fear of liability or because of the inconvenience and cost of
multilingual labeling.
However, although Europeans are similar to Americans in many important
ways, two uniquely American notions stand rmly in the way of implementation
of an ocial language of the United States. One is our newfound emphasis on
diversity, the support and respect of which is inconsistent with imposition of the
English language on all who arrive here. The second is the often idealistic, quite
pervasive view of the rights of individuals taking precedence over the needs of
the state{combined with a erce litigiousness to enforce those rights. Despite
the popular support for national ocial English legislation, Congress will no
doubt shy away from this issue, fearing loss of constituent support or even a
successful Equal Protection challenge. Thus establishment of English as the
ocial language is in the hands of FDA, which needs not make any regulatory
changes at this time to sustain this policy. Yet FDA cannot be certain that
other state courts will not go the opposite direction from California's, imposing
tort liability and upsetting the national balance.
On the other side of the spectrum, Congress or the FDA could move to
mandate labeling in certain languages other than English on
8foods and drugs marketed in the U.S. Such a determination would leave open
a number of complex questions, such as feas-ibility given small space on labels,
which languages merit inclusion, and whether to and how to divide the U.S.
into several dierent markets for the purposes of labeling.
The arguments that FDA should act, through rulemaking, to mandate foreign|
language labeling are extremely compelling. The FDA has already interpreted
its primary mandate as to protect the consumer, often the most vulnerable
consumer. For instance, according to FDA regulations, warnings on nonpre-
scription drugs must be written in such terms as to render them likely to be
read and understood by the ordinary individual, including individuals of low
comprehension, under ordinary conditions of purchase and use (italics added).~
A court described FDA's purpose as to protect the public, the vast multitude
which includes the ignorant, the unthinking and the credulous.~IU As relates
to a warning on a label, non-English speakers are very much like the ignorant
in that through no fault of their own, they do not have the protections aorded
to a person of normal comprehension, and the FDA'S mandate could extend
to them as well. Non-English speakers indeed number in the millions: of the
32 million Americans who speak another language at home, 21 percent or 6.7
million speak English only poorly or not at allY Certainly in the case of drugs,
where critical warnings are routinely needed, the knowing failure to relay such
information to an easily identiable group of people could be said to amount to
disregard for the lives 6.7 million Americans.
9Furthermore, there is a particular need for carefully translated labels on drug
labels simply because of the sophisticated vocabulary involved; even if someone
in the family speaks English well enough to interact in society, it is likely that
he or she would not recognize or translate properly the names of diseases or
symptoms. From this perspective, the need for food labels in foreign languages
is less pressing. Nutrition labelling is not so clearly a matter of life and death,
and if a
person wishes to avoid a particular ingredient for health or allergy reasons,
he or she could very easily learn to recognize one or two words in English.
Thus, the consumer is the cheapest cost| avoider in the case of food labels,
but industry is in an unique position to avoid harm in the case of drugs.
However, a determination that drugs should be labeled in foreign languages
begs the inevitable question: which languages? As Plough protested in the
Ramirez case, there are over 148 languages spoken in the United States.26 In
California, the legislature has used a numerical threshold of aected persons
speaking a given language to determine whether translation is necessary; for
example, government documents must be provided in other languages if over
three percent of the population speaks that language.V The following chart28
illustrates the size of populations speaking foreign languages at home in the U.S.
according to the 1990 Census:
10Pct who speak % tot pop.
Lancuace Total steakers % total ~oQ. Enalish Doorlv w/~oor Enalish
Spanish 17,339,172 6.97 26.0 1.8
French 1,702,176 0.68 9.3 0.06
German 1,547,099 0.62 6.5 0.04
Italian 1,308,648 0.52 1.6 0.008
Chinese 1,249,213 0.50 29.9 0.15
Polish 723,483 0.29 13.6 0.04
Korean 626,478 0.25 30.1 0.0?
Vietnamese 507.069 0.20 28.2 0.05
Totals: 31,844,979* 13.10* 6.7*
*Includes all languages, not exclusively those listed above
It is clear that on a national basis, only Spanish is statistically signicant
enough to merit use on drug labels, with nearly seven percent of the population
speaking it at home, and nearly two percent without English. However, it is
unclear whether these gures justify marketing in two languages all across the
U.S. when very few Spanish speakers are found in the Midwest, for instance.
Such an approach further ignores the sizeable Asian immigrant populations{with
very high rates of non-prociency in English{who are largely clustered in a few
areas of the country. Perhaps percentage thresholds and labeling requirements
could be broken down by state, which would allow foreign language labels to
best serve their target populations. In California, for instance, the only language
meeting a 3% cuto is Spanish (18.1%), while Chinese (1.8%) and Tagalog~
(1.5%) meet a 1% cuto.30 This suggests that such an approach would not be
very burdensome||not even approaching the labeling nightmare envisioned
by Plough{since very few states and very few languages would even qualify.
Further, no one could doubt that the drug companies would comply or take their
drugs of f the market if the states passed foreign-language labeling requirements.
The disadvantages of a threshold-level mandated approach
11include feasibility of labeling, diculty of translation and cost to manu-
facturers. Due to the requirement that any representation in a foreign lan-
guage triggers the need to include all mandatory information in that language,
space for labeling could be problematic. However, this could be easily alleviated
if the FDA promulgated a regulation allowing a conspicuous foreign language
statement such as IMPORTANT: READ ENCLOSED SPANISH-LANGUAGE
INFORMATION to be outside the denition of a representation, and a short in-
formation sheet matching the English label could be included in the package.31
As to the oft-raised protest that too much labeling will throw consumers into
a muddle, unable to nd [their] own lang|uage,32 as indicated above, only a
very few languages will meet the statutory cuto, so that is unlikely.
Diculty of obtaining accurate translations was noted by the FDA as one
of the reasons it revoked its rule establishing a requirement to include patient
package inserts, with Spanish translations available from doctors or pharma-
cists, in prescription drug packaging.33 It is unclear, however, how important
this problem was to its nal decision, as the proposal was fraught with many
other diculties24 This, in itself, should not be a sucient reason to deny pro-
tection to such a signicant segment of society (and it is curious that Japanese
electronics manufacturers seem to have no such problem in creating their mul-
tilingual instruction booklets). Cost is another problem: it will surely cost
manufacturers to obtain and print translations. However, the cost should not
be as staggering as other label changes which have been required by the FDA
in the name of safety
12and health,35 and as already discussed above, the industry is the superior
cost|avoider in the area of warnings on drugs.
A number of intermediate solutions exist, two of which are predicated on
tort liability. Congress could armatively reinstate tort liability by amending
the law concerning labeling to include such a statement as statutory compliance
shall not operate as a complete defense to tort liability. This would essentially
work to bring about the California Court of Appeals' approach based on what a
reasonable person or reasonable manufacturer would do with respect to language
labeling. The advantage to such an approach is that consumers would be pro-
tected in ultimately the most eective and thorough way, as the manufacturers
would naturally be driven to spend most on labeling in areas densely populated
by non-English speakers, choosing the most frequently-encountered foreign lan-
guages for their labels to insulate themselves from liability. Free-marketeers
would also favor this approach since it allows manufacturers to make their own
cost| benef it analyses, free from expensive government mandates. However,
the disadvantage of this method is also rather signicant: using foreseeability
analysis, it is undeniably foreseeable that a drug product could come into the
hands of a speaker of any one of the 148 languages found in the United States.
Juries moved by sympathy for the injured and blameless plaintis would view
drug companies as deep pockets, awarding astronomical sums that would even-
tually work to reduce the number of companies willing to market the helpful
drugs Americans want and need.
For this reason, a compromise, advertising|based approach
13within the tort system might be appropriate. Like many companies, Plough,
Inc. was aggressively targeting the Spanish-language market in California at
the time of the Ramirez lawsuit. The California Supreme Court left open the
possibility of tort liability premised upon the content of foreign|language ad-
vertising. For example, we do not decide whether a manu|facturer would be
liable to a consumer who detrimentally relied upon foreign-language advertising
that was materially misleading as to product risks and who was unable to read
English language warnings that accurately described the risks.36 That such a
lawsuit could still be viable is comforting, yet it does not respond to the inher-
ent unfairness of allowing manufacturers to advertise in a foreign language|
|knowingly appealing to just those consumers who do not speak English{and
then denying consumers recovery when the manufacturers fail to communicate
mandatory protective warnings in that same langauge. Premised almost on an
unjust enrichment theory, tort liability on an if|advertised in a foreign language
basis also allows for the same market eciencies in terms of consumer coverage
as discussed above. If a market of non|English speakers is large enough, the
attraction of sales to that segment of society will oset the cost of the translated
labels and ensure that those consumers receive warnings in a language they can
understand.
Despite popular support for a policy of English as the ocial language of
the United States, this policy does not appear to be consistent with other values
strongly held by our nation, most notably protection of minorities against ma-
jorities and consumer protection. Political inertia and other preoccup|ations
14mean that a new solution is not likely to be put forth by Congress or the FDA
without societal pressure. However, such pressure could arise from manufactur-
ers if other courts are willing to let cases go to juries, as the California court was
not, or from consumers if other well-publicized instances of preventable injury or
death occur. If Congress or the FDA values the lives of our new immigrants, the
optimal solution, striking a balance between eciency and maximal protection,
appears to be regional or statebased percentage thresholds for federally man-
dated foreign-language inserts. Alternatively, tort liability for failure to warn
in a foreign language if manufacturers advertise in that foreign language is the
most eective and fair market|based solution.
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